Booming antibodies 2001
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma

Tuesday, November 30, 2021

Allakos Inc a biotechnology company developing lirentelimab AK for the treatment of eosinophil and mast cellrelated diseases today announced it has initiated a randomized doubleblind placebocontrolled Phase clinical trial of subcutaneous SC lirentel...

ATyr Pharma and FUJIFILM Diosynth Biotechnologies Announce Manufacturing Agreement for aTyr’s Lead Therapeutic Candidate ATYR1923

Tuesday, November 30, 2021

ATyr Pharma Inc a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways and FUJIFILM Diosynth Biotechnologies a leading contract development and manufacturing organization CDMO for...

Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257

Tuesday, November 30, 2021

Treadwell Therapeutics a clinical stage biotechnology company developing novel therapeutics for highly aggressive cancers today announced that the US Food and Drug Administration FDA has approved its Investigational New Drug IND application to evalua...

OriCiro Genomics Launches New enzymatic DNA synthesis tool for commonly used vectors

Monday, November 29, 2021

OriCiro Genomics Inc a pioneer in cellfree synthesis and amplification of genomescale large DNA for advanced therapeutics and synthetic biology today announced the launch of OriCiro CellFree Switching systemIn the biological sciences cellbased clonin...

Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma

Monday, November 29, 2021

Todos Medical Ltd a comprehensive medical diagnostics and related solutions company today announced it has entered into a binding agreement to acquire all CL protease biologyrelated assets owned by NLC Pharma and form a majorityowned subsidiary calle...

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

Monday, November 29, 2021

Valneva SE a specialty vaccine company and IDT Biologika today announced their collaboration for the production of Valnevas inactivated COVID vaccine candidate VLA This follows last weeks announcement that Valneva signed an Advance Purchase Agreement...

Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric

Monday, November 29, 2021

Celularity Inc a clinicalstage biotechnology company developing placentalderived allogeneic cell therapies today announced the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for the use of CYNK in combina...

Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000

Monday, November 29, 2021

Avacta Group plc a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and preCISION platforms is pleased to announce that the US Food and Drug Administration FDA h...

Relief Reports that its U.S. Collaboration Partner has Identified a Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19

Monday, November 29, 2021

RELIEF THERAPEUTICS Holding SA a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need reported today that the parent company of its collaboration partner NRx Pharmaceuticals Inc Nasdaq NR...

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Monday, November 29, 2021

Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID Treatment Trial ACTT using its proprietary Advantage eClinical system The ACTT trial assessed the efficacy and safety of interfer...